Mazdutide

What it is: A dual GLP-1 / glucagon agonist developed in China — similar profile to Survodutide. Targets both appetite and energy burn.

What it does: Expect strong weight loss, appetite suppression, improved blood sugar, and possible improvements in fatty liver.

How it's used: Weekly subcutaneous injection.